5/4/2024

Tramadol Tablets

Products Affected - Description

- Tramadol tablet, Amneal, 50 mg, bottle, 100 count, NDC 60219-2348-01
- Tramadol tablet, Amneal, 50 mg, bottle, 500 count, NDC 60219-2348-05
- Tramadol tablet, Amneal, 50 mg, bottle, 1,000 count, NDC 60219-2348-07
- Tramadol tablet, Sun Pharma, 50 mg, bottle, 500 count, NDC 57664-0377-13 - discontinued
- Tramadol tablet, Teva, 50 mg, bottle, 500 count, NDC 00093-0058-05

Reason for the Shortage

- Amneal did not provide a reason for the shortage.
- Major discontinued tramadol tablets.
- Marlex discontinued tramadol tablets in January 2020.
- Mylan discontinued tramadol tablets in late 2021.
- Sun Pharma has tramadol tablets available. Sun Pharma discontinued tramadol 50 mg tablets in 500-count bottles.
- Teva did not provide a reason for the shortage.
- Virtus discontinued tramadol tablets.

Available Products

- Tramadol tablet, Sun Pharma, 50 mg, bottle, 100 count, NDC 57664-0377-08
- Tramadol tablet, Sun Pharma, 50 mg, bottle, 1000 count, NDC 57664-0377-18
- Tramadol tablet, Teva, 50 mg, bottle, 100 count, NDC 00093-0058-01

Estimated Resupply Dates

- Amneal has all tramadol products on allocation.
- Teva has tramadol 50 mg in 500 count bottles on intermittent back order and the company is releasing product as it becomes available.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.